Tragara Pharmaceuticals' Apricoxib Reverses EMT, A Key Process For Cancer Progression And Metastasis
5/28/2011
Tragara Pharmaceuticals, Inc. announced that apricoxib (Capoxigem®, TG01), its novel COX-2 inhibitor in development for select cancer types, demonstrated reversal of the epithelial-mesenchymal transition (EMT) in xenograft models of several types of solid tumors...
Cancer Cells Accelerate Aging And Inflammation In The Body To Drive Tumor Growth
5/28/2011
Researchers at the Kimmel Cancer Center at Jefferson have shed new light on the longstanding conundrum about what makes a tumor grow and how to make it stop. Interestingly, cancer cells accelerate the aging of nearby connective tissue cells to cause inflammation, which ultimately provides "fuel" for the tumor to grow and even metastasize...
When Cancer Runs In The Family
5/28/2011
5% to 10% of all breast cancers are monogenic in origin. In other words, there is a mutation of the genes BRCA1, BRCA2 or other high-risk genes...
New Treatment Dissolves Blood Clots In Brain Tissue
5/28/2011
A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective, according to a multicenter clinical trial led by Johns Hopkins researchers...
Memorial Day Sun: Discount Sunscreen By Target Proves Best
5/27/2011
Memorial Day and the official kick-off to Summer is upon us. That means heat, sun, fun and burns...
Nuvilex, Inc. Announces Completion Of Acquisition Of Pancreatic Cancer Treatment Technology
5/27/2011
Nuvilex, Inc. (OTCQB: NVLX) announces it has completed the acquisition of pancreatic cancer treatment technology from a world leader in living-cell encapsulation technology...
Prostate Cancer Drug Developers Win Royal Society Of Chemistry Award, UK
5/27/2011
A team of scientists at The Institute of Cancer Research (ICR) has won a prestigious Royal Society of Chemistry (RSC) award for the discovery and clinical development of prostate cancer drug abiraterone. Professor Mike Jarman and colleagues at the ICR have today been honoured with the 2011 RSC Teamwork in Innovation Award...
Three Renowned Scientists Recruited For Cancer, Physics And Chemistry Research At Rice
5/27/2011
Herbert Levine, JosE Onuchic and Peter Wolynes will bring leading national labs to Rice's BioScience Research Collaborative, including an NSF Center for Theoretical Biological Physics, thanks in part to a CPRIT grant Three of the country's leading researchers in physics and chemistry have been recruited to Rice University, thanks in part to a grant from the Cancer Preventi...
Dominating Groups Of Cooperative Bacteria Halted By 'Policing' Cheaters
5/27/2011
For cooperation to persist in the often violently competitive realm of bacteria, cheaters must be kept in line. Two Indiana University Bloomington biologists have learned that in one bacterium, at least, bacterial cooperators can evolve to "police" the cheaters and arrest their bids for dominance...
Insights On Humans, Parasites And Iron Deficiency From C. elegans Study
5/27/2011
Using a tiny bloodless worm, University of Maryland Associate Professor Iqbal Hamza and his team have discovered a large piece in the puzzle of how humans, and other organisms safely move iron around in the body...